← Leaderboards
Robert Francois Hobbs
Johns Hopkins University
$5,138,973
Attributed
$8,643,733
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,643,733 · 4
By mechanism
R01$7,349,729 · 3
P01$1,294,004 · 1
Top collaborators
- George Sgouros11 shared
- Paul W Ladenson6 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Daniel Lyndon Jaffe Thorek$4,988,087
- Yong Du$6,226,551
- Martin G Pomper$38,517,075
- Paul W Ladenson$925,189
- Catherine M Gordon$5,650,865
Others in their field
Top investigators on “Cancer Therapy”
- David Heimbrook · Leidos Biomedical Research, Inc.$366,127,178
- Norman Wolmark · Nsabp Foundation, Inc.$292,963,206
- Gregory H Reaman · National Childhood Cancer Foundation$271,061,526
- Peter C Adamson · National Childhood Cancer Foundation$269,808,480
- Charles A Coltman · Southwest Oncology Group$178,303,465
- Sudhir Raju · Ctis, Inc.$162,436,462
Research focus
Cancer TherapyDosimetryMethodologyTreatment PlanningRadiopharmaceuticalsToxic EffectUnited States National Institutes Of HealthDoseClinical TrialsComputer SoftwareTumorModalityOrgan3-DimensionalInterestTargeted DeliveryGrantRadioactiveBindingMapsKidneyNormal Tissue MorphologyCancer PatientBase
Grant awards (18)
Combination Radiopharmaceutical Therapy and External Beam Radiotherapy$436,988
R01 · FY2025 · CA · contact PI
Macro-to-micro (M2µ) Activity Apportionment for αRPT$321,148
P01 · FY2025 · CA · contact PI
Combination Radiopharmaceutical Therapy and External Beam Radiotherapy$531,211
R01 · FY2024 · CA
Macro-to-micro (M2µ) Activity Apportionment for αRPT$473,956
P01 · FY2024 · CA · contact PI
Combination Radiopharmaceutical Therapy and External Beam Radiotherapy$547,986
R01 · FY2023 · CA
Macro-to-micro (M2µ) Activity Apportionment for αRPT$498,900
P01 · FY2023 · CA · contact PI
Dose-Response in Radionuclide Therapy$637,623
R01 · FY2022 · CA
Combination Radiopharmaceutical Therapy and External Beam Radiotherapy$547,986
R01 · FY2022 · CA
Dose-Response in Radionuclide Therapy$665,374
R01 · FY2021 · CA
Combination Radiopharmaceutical Therapy and External Beam Radiotherapy$122,185
R01 · FY2021 · CA
Dose-Response in Radionuclide Therapy$665,374
R01 · FY2020 · CA
Combination Radiopharmaceutical Therapy and External Beam Radiotherapy$579,259
R01 · FY2020 · CA
Dose-Response in Radionuclide Therapy$668,984
R01 · FY2019 · CA
Dose-Response in Radionuclide Therapy$684,679
R01 · FY2018 · CA
Modeling Targeted Alpha Particle Therapy of Cancer$320,698
R01 · FY2015 · CA · contact PI
Modeling Targeted Alpha Particle Therapy of Cancer$311,077
R01 · FY2014 · CA · contact PI
Modeling Targeted Alpha Particle Therapy of Cancer$295,651
R01 · FY2013 · CA · contact PI
Modeling Targeted Alpha Particle Therapy of Cancer$334,654
R01 · FY2012 · CA · contact PI